Bacterial vaginosis and adverse outcomes among full-term infants: a cohort study

Table 3 Associations between bacterial vaginosis and adverse outcomes among full-term infants (37 weeks or greater gestation), Washington State, 2003-2013 (N = 11,354), adjusted for gestational age, maternal age, and maternal race, and additionally adjusted for the presence of chorioamnionitis or meconium

	BV exposed		BV unexposed		aRR	95 % CI
	N = 2198		N = 9156		aRR	95 % CI
	n	%	n	%
Assisted ventilation at birth	98	4.5	328	3.6	1.28	1.02–1.61
additionally adjusted for chorioamnionitis	98	4.5	328	3.6	1.28	1.02–1.61
additionally adjusted for meconium	98	4.5	328	3.7	1.22	0.97–1.53
Admission to NICU at birth	88	4.1	269	3.0	1.42	1.11–1.82
additionally adjusted for chorioamnionitis	88	4.1	269	3.0	1.45	1.13–1.85
additionally adjusted for meconium	88	4.1	267	3.0	1.34	1.05–1.72
Neonatal sepsis	48	2.2	125	1.4	1.60	1.13–2.27
additionally adjusted for chorioamnionitis	48	2.2	125	1.4	1.67	1.19–2.35
additionally adjusted for meconium	48	2.2	125	1.4	1.51	1.06–2.14
Fetal Mortality	3	0.1	12	0.1	1.15*	0.27–4.96
additionally adjusted for chorioamnionitis	3	0.1	12	0.1	1.14*	0.27–4.88
additionally adjusted for meconium	0	0.0	3	0.0	-	-
Infant mortality	3	0.1	24	0.3	0.39	0.12–1.28
additionally adjusted for chorioamnionitis	3	0.1	24	0.3	0.39	0.12–1.27
additionally adjusted for meconium	3	0.1	23	0.3	0.40	0.12–1.34

BV bacterial vaginosis, aRR adjusted risk ratio, CI confidence interval, NICU neonatal intensive care unit
*further adjusted for presence of sexually transmitted infections (syphilis, gonorrhea, chlamydia, and/or genital herpes)

ISSN: 1471-2393